Literature DB >> 15504035

Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin: a zinc-dependent mRNA binding protein affected by posttranslational modifications.

Heping Cao1.   

Abstract

Tristetraprolin (TTP) is a hyperphosphorylated protein that destabilizes mRNA by binding to an AU-rich element (ARE). Mice deficient in TTP develop a severe inflammatory syndrome. The biochemical properties of TTP have not been adequately characterized, due to the difficulties in protein purification and lack of a high-titer antiserum. Full-length human TTP was expressed in human HEK293 cells and purified to at least 70% homogeneity. The purified protein was free of endogenous ARE binding activity, and was used for investigating its size, zinc dependency, and binding kinetics for tumor necrosis factor alpha mRNA ARE. A high-titer rabbit antiserum was raised against the MBP-hTTP fusion protein expressed in Escherichia coli. Cellular localization studies of the transfected cells indicated that approximately 80% of the expressed TTP was in the cytosol, with 20% in the nuclei. TTP from both locations bound to the ARE and formed similar complexes. The purified TTP was shown to be intact by N-terminal His-tag purification, C-terminal peptide sequencing, and mass spectrometry analysis. Results from size exclusion chromatography are consistent with the predominant form of active TTP being a tetramer. TTP's ARE binding activity was increased by 10 microM Zn(2+). The half-maximal binding of TTP from HEK293 cells was approximately 30 nM in assays containing 10 nM ARE. This value was about twice that of TTP from E. coli. TTP from HEK293 cells was highly phosphorylated, and its electrophoretic mobility was increased by alkaline phosphatase treatment and somewhat by T271A mutation, but not by PNGase F or S186A mutation. The gel mobility of TTP from E. coli was decreased by in vitro phosphorylation with p42/ERK2 and p38 mitogen-activated protein kinases. These results suggest that TTP's zinc-dependent ARE binding affinity is reduced by half by posttranslational modifications, mainly by phosphorylation but not by glycosylation, in mammalian cells. The results support a model in which each subunit of the TTP tetramer binds to one of the five overlapping UUAUUUAUU sequences of the ARE, resulting in a stable TTP-ARE complex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504035      PMCID: PMC1351390          DOI: 10.1021/bi049014y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  56 in total

1.  A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence.

Authors:  R N DuBois; M W McLane; K Ryder; L F Lau; D Nathans
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

2.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

3.  AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation.

Authors:  C T DeMaria; G Brewer
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

4.  Quantitation of protein.

Authors:  C M Stoscheck
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

5.  Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression.

Authors:  L Fransen; R Müller; A Marmenout; J Tavernier; J Van der Heyden; E Kawashima; A Chollet; R Tizard; H Van Heuverswyn; A Van Vliet
Journal:  Nucleic Acids Res       Date:  1985-06-25       Impact factor: 16.971

6.  Metal binding properties and secondary structure of the zinc-binding domain of Nup475.

Authors:  M T Worthington; B T Amann; D Nathans; J M Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Mitogens stimulate the rapid nuclear to cytosolic translocation of tristetraprolin, a potential zinc-finger transcription factor.

Authors:  G A Taylor; M J Thompson; W S Lai; P J Blackshear
Journal:  Mol Endocrinol       Date:  1996-02

8.  Promoter analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin.

Authors:  W S Lai; M J Thompson; G A Taylor; Y Liu; P J Blackshear
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

9.  Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro.

Authors:  G A Taylor; M J Thompson; W S Lai; P J Blackshear
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

10.  A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency.

Authors:  G A Taylor; E Carballo; D M Lee; W S Lai; M J Thompson; D D Patel; D I Schenkman; G S Gilkeson; H E Broxmeyer; B F Haynes; P J Blackshear
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

View more
  33 in total

Review 1.  The roles of TTP and BRF proteins in regulated mRNA decay.

Authors:  Sandhya Sanduja; Fernando F Blanco; Dan A Dixon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011 Jan-Feb       Impact factor: 9.957

2.  Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment.

Authors:  Sandra L Clement; Claudia Scheckel; Georg Stoecklin; Jens Lykke-Andersen
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

3.  Sequence-specific RNA binding mediated by the RNase PH domain of components of the exosome.

Authors:  John R Anderson; Devi Mukherjee; Karthika Muthukumaraswamy; Karen C M Moraes; Carol J Wilusz; Jeffrey Wilusz
Journal:  RNA       Date:  2006-08-15       Impact factor: 4.942

4.  A Knock-In Tristetraprolin (TTP) Zinc Finger Point Mutation in Mice: Comparison with Complete TTP Deficiency.

Authors:  Wi S Lai; Deborah J Stumpo; Lianqun Qiu; Roberta Faccio; Perry J Blackshear
Journal:  Mol Cell Biol       Date:  2018-01-29       Impact factor: 4.272

5.  Protein phosphatase 2A (PP2A) is increased in old murine B cells and mediates p38 MAPK/tristetraprolin dephosphorylation and E47 mRNA instability.

Authors:  Daniela Frasca; Maria Romero; Ana Marie Landin; Alain Diaz; Richard L Riley; Bonnie B Blomberg
Journal:  Mech Ageing Dev       Date:  2010-02-26       Impact factor: 5.432

Review 6.  Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.

Authors:  Seth A Brooks; Perry J Blackshear
Journal:  Biochim Biophys Acta       Date:  2013-02-18

7.  Phosphorylation of human tristetraprolin in response to its interaction with the Cbl interacting protein CIN85.

Authors:  Vishram P Kedar; Martyn K Darby; Jason G Williams; Perry J Blackshear
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

8.  Phosphorylation of recombinant tristetraprolin in vitro.

Authors:  Heping Cao; Rui Lin
Journal:  Protein J       Date:  2008-04       Impact factor: 2.371

9.  A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion.

Authors:  Neil Warner; Aaron Burberry; Maria Pliakas; Christine McDonald; Gabriel Núñez
Journal:  J Biol Chem       Date:  2014-08-28       Impact factor: 5.157

10.  Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation.

Authors:  Khadija Essafi-Benkhadir; Cercina Onesto; Emmanuelle Stebe; Christoph Moroni; Gilles Pagès
Journal:  Mol Biol Cell       Date:  2007-09-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.